tirzepatide vs semaglutide weight loss effectiveness comparison Tirzepatide: Which GLP-1 Wins for Loss? semaglutide vs tirzepatide comparison efficacy

During the 40- to 104-week treatment periods with ADA sampling conducted up to 44 to 108 weeks in seven clinical trials in adults with type 2 diabetes mellitus [see Clinical Studies (14)], 51% (2,570/5,025) of MOUNJARO-treated patients developed anti-tirzepatide antibodies

For individuals struggling with weight loss or managing type 2 diabetes, GLP-1 offers a highly effective, scientifically-backed solution

Administered once weekly, it has been shown to help participants lose a significant percentage of their excess weight over a clinical trial period

Final Verdict

The results are visible with even-toned complexion and healthy glow which adds on to your confidence every day